Woman and Man
- | Country :
- Germany
- | organs : -
- | Specialty : -
Extract
This observational study will assess the therapeutic efficiency, the treatment schedules and handling procedures, and the safety profile of MabThera/Rituxan (rituximab) in routine care in patients with chronic lymphocytic leukemia. Data from patients will be collected for a total of 24 months.
Inclusion criteria
- Lymphocytic Leukemia, Chronic